Generali Investments Management Co LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 80.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,024 shares of the healthcare conglomerate’s stock after buying an additional 4,030 shares during the quarter. UnitedHealth Group comprises 0.8% of Generali Investments Management Co LLC’s investment portfolio, making the stock its 26th largest holding. Generali Investments Management Co LLC’s holdings in UnitedHealth Group were worth $3,751,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in UNH. Ares Financial Consulting LLC raised its holdings in shares of UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock valued at $174,000 after purchasing an additional 28 shares in the last quarter. Rockland Trust Co. increased its position in UnitedHealth Group by 1.1% during the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock worth $1,076,000 after buying an additional 29 shares during the last quarter. Matrix Trust Co lifted its position in shares of UnitedHealth Group by 24.8% in the second quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate’s stock worth $61,000 after buying an additional 29 shares during the last quarter. Integral Investment Advisors Inc. increased its holdings in shares of UnitedHealth Group by 4.0% during the 2nd quarter. Integral Investment Advisors Inc. now owns 784 shares of the healthcare conglomerate’s stock valued at $326,000 after acquiring an additional 30 shares during the last quarter. Finally, Bell Investment Advisors Inc boosted its position in UnitedHealth Group by 14.4% during the first quarter. Bell Investment Advisors Inc now owns 246 shares of the healthcare conglomerate’s stock worth $67,000 after purchasing an additional 31 shares during the period. 87.86% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the company’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total value of $205,000.00. Following the sale, the chief executive officer directly owned 16,497 shares in the company, valued at $6,763,770. This represents a 2.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Trading Up 0.4%
Shares of UnitedHealth Group stock opened at $408.70 on Tuesday. The company’s fifty day moving average price is $414.66 and its two-hundred day moving average price is $351.47. The firm has a market capitalization of $371.16 billion, a PE ratio of 26.30, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $252.14 and a 52-week high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The business had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm’s revenue was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.
UnitedHealth Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is 59.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Read More
- Five stocks we like better than UnitedHealth Group
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
